Evidence & regulatory context
- Mechanism
- CHEMBL NOT QUERIED: no single defined chemical entity exists. This is a plant seed lectin, both a native protein purified from Bauhinia variegata and a recombinant isoform expressed heterologously; ChEMBL does not index crude plant lectins as drug entities.
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseWoundSwiss albinoMalen = 84 mice, seven groups of 12Topical200 micrograms per mL solution, single daily dose of 20 mic…Started immediately after the surgical procedure
Model: Surgically created dorsal excisional skin wound
Wound closure was fastest with rBVL-1, complete by postoperative day 7, while the native lectin closed wounds by day 12 and outperformed controls, with reconstruction of all skin layers and increased keratin deposition.
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.
